SOUTH SAN FRANCISCO, Calif., Nov. 26, 2025 /PRNewswire/ -- Rigel Pharmaceuticals. Inc. (Nasdag: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, todav announced that Dean Schorno, the company's chief financial officer, will present a company overview at the Piper Sandler 37 Annual Healthcare Conference on Wednesday, December 3, 2025, at 8:30 am ET. To access the live webcast or archived recording, visit the Investor Relations section of the company's website at ww ...